Comparisons between densitometric, biochemical, and hormonal variables and bone remodeling markers of exclusive breastfeeding mothers (EBF) 15 days postpartum and the same EBF moth... حسب Larissa Brazolotto Ferreira (17671168)

الموضوعات:

Loss of mammary fitness and virulence by <i>M</i>. <i>bovis</i> 0690::Tn mutant. حسب Aga E. Gelgie (17661720)

الموضوعات:

Primary and secondary efficacy end points (intention-to-treat population). حسب Benjamin R. Lewis (22279166)

الموضوعات:

Flowchart of the exclusive breastfeeding mothers (EBF) and the exclusive breastfeeding mother-donors (EBF+) who participated in the study. حسب Larissa Brazolotto Ferreira (17671168)

الموضوعات:

Timeline of monitoring of exclusive breastfeeding mothers (EBF) and exclusive breastfeeding – donors (EBF+). حسب Larissa Brazolotto Ferreira (17671168)

الموضوعات:

Demographic and clinical characteristics of participants at baseline. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Study-related adverse events. حسب Benjamin R. Lewis (22279166)

الموضوعات:

<i>M</i>. <i>bovis</i> 0690::Tn mutant failed to elicit the recruitment of neutrophils into milk spaces. حسب Aga E. Gelgie (17661720)

الموضوعات:

Data supporting the findings of this study. حسب Aga E. Gelgie (17661720)

الموضوعات:

Comparison of densitometric, biochemical, and hormonal variables, and bone turnover markers of EBF + 6 months versus EBF + one year postpartum. حسب Larissa Brazolotto Ferreira (17671168)

الموضوعات:

Study flow chart. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Change in QIDS-SR-16 and MBI-HSS-MP by Treatment Group. حسب Benjamin R. Lewis (22279166)

الموضوعات:

I Optimal design for optimization of Axitinib loaded Spanlastics. حسب Randa Mohammed Zaki (21637175)

الموضوعات:

Study CONSORT diagram. حسب Benjamin R. Lewis (22279166)

الموضوعات:

ANOVA for I optimal design of Axitinib loaded Spanlastics. حسب Randa Mohammed Zaki (21637175)

الموضوعات:

The kinetic release data of the optimized formula compared to drug suspension. حسب Randa Mohammed Zaki (21637175)

الموضوعات:

Change in Demoralization Scale (DSII) by Treatment Group. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Change in Watt’s Connectedness Scale (WCS), General Connectedness by Treatment Group. حسب Benjamin R. Lewis (22279166)

الموضوعات:

Oligonucleotides used in this study. حسب Aga E. Gelgie (17661720)

الموضوعات:

Open data. حسب Larissa Brazolotto Ferreira (17671168)

الموضوعات: